Further experiments are underway to evaluate the effect of Rap2B on cell migration and invasion by regulating Ca2+-related ERK1/2 signaling pathway using an in vivo tumor mouse model, hoping that we can provide a useful therapeutic strategy to help restrain the progression of breast cancer. The gene discussed is MAPK3; the disease is neoplasm.